Overview

Children, Perennial Allergic Rhinitis (PAR), l-t Growth

Status:
Completed
Trial end date:
2003-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effect of Rhinocort nasal spray with placebo on growth in children with perennial allergic rhinitis over 12 months.
Phase:
Phase 4
Details
Lead Sponsor:
AstraZeneca
Treatments:
Budesonide